poil-1 schreef op 4 januari 2019 15:58:
Quantum Genomics to Present at Biotech Showcase 2019
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company
specializing in the development of a new drug class that directly targets the brain to treat resistant
hypertension and heart failure, today announced that it will be presenting at the Biotech Showcase
in San Francisco, CA, being held on January 7-9, 2019. Chief Executive Officer of Quantum Genomics,
Jean-Philippe Milon, and the Management team, will be giving a presentation and meeting with
investors and pharmaceutical companies.
Event: Biotech Showcase™
Date Tuesday, January 8, 2019
Time: 3:30 pm PT
Location: Hilton San Francisco Union Square, San Francisco, CA (Yosemite A)
For investors attending the Biotech Showcase, please contact Quantum Genomics Investor Relations
team to schedule a meeting with management at
jgreen@edisongroup.com.
Groet, poil